• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
[Answer to the "Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure" correspondence].[对“COVID-19合并心力衰竭患者的糖皮质激素治疗”信件的回复]
Rev Clin Esp. 2022 May;222(5):310-311. doi: 10.1016/j.rce.2021.11.001. Epub 2021 Nov 20.
2
Answer to the "Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure" correspondence.对“COVID-19合并心力衰竭患者的糖皮质激素治疗”信件的回复。
Rev Clin Esp (Barc). 2022 May;222(5):310-311. doi: 10.1016/j.rceng.2021.11.001. Epub 2022 Jan 24.
3
Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure.新冠病毒病合并心力衰竭患者的糖皮质激素治疗
Rev Clin Esp (Barc). 2022 May;222(5):309-310. doi: 10.1016/j.rceng.2021.11.002. Epub 2022 Jan 31.
4
[Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure].[新型冠状病毒肺炎合并心力衰竭患者的糖皮质激素治疗]
Rev Clin Esp. 2022 May;222(5):309-310. doi: 10.1016/j.rce.2021.11.002. Epub 2021 Nov 20.
5
Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco . Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases' by Giollo .风湿性疾病活动、糖皮质激素使用与2019冠状病毒病。对以下内容的回应：“关于‘风湿性疾病患者2019冠状病毒病住院相关特征：来自2019冠状病毒病全球风湿病联盟医生报告登记处的数据’的通信”，作者为詹弗兰切斯科。乔洛指出：“在风湿性肌肉骨骼疾病患者中，疾病活动而非糖皮质激素治疗可能与2019冠状病毒病的严重程度相关。”
Ann Rheum Dis. 2022 Nov;81(11):e223. doi: 10.1136/annrheumdis-2020-218910. Epub 2020 Sep 7.
6
Association between glucocorticoid use and all-cause mortality in critically ill patients with heart failure: A cohort study based on the MIMIC-III database.糖皮质激素使用与重症心力衰竭患者全因死亡率之间的关联：一项基于MIMIC-III数据库的队列研究。
Front Pharmacol. 2023 Jan 12;14:1118551. doi: 10.3389/fphar.2023.1118551. eCollection 2023.
7
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco . Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases.关于吉安弗兰切斯科所著《风湿性疾病患者新冠病毒肺炎住院相关特征：来自新冠病毒肺炎全球风湿病联盟医生报告登记处的数据》的通信。在风湿性肌肉骨骼疾病患者中，疾病活动度而非糖皮质激素治疗，可能与新冠病毒肺炎的严重程度相关。
Ann Rheum Dis. 2022 Nov;81(11):e222. doi: 10.1136/annrheumdis-2020-218845. Epub 2020 Sep 7.
8
[Clinical effect of Shenfu injection combined with glucocorticoid on patients with acute left heart failure complicated with bronchospasm].参附注射液联合糖皮质激素治疗急性左心衰竭合并支气管痉挛患者的临床疗效
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Dec;35(12):1298-1303. doi: 10.3760/cma.j.cn121430-20230726-00557.
9
Response to: 'Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'' by Jeny .对珍妮的《关于“结节病患者糖皮质激素诱导的COVID-19复发”的通信》的回复 。
Ann Rheum Dis. 2022 Dec;81(12):e242. doi: 10.1136/annrheumdis-2020-218983. Epub 2020 Oct 1.
10
Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience.糖皮质激素治疗 COVID-19 肺炎患者的临床疗效：一项单中心经验。
Biomed Pharmacother. 2020 Oct;130:110529. doi: 10.1016/j.biopha.2020.110529. Epub 2020 Jul 28.

本文引用的文献

1
[Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure].[新型冠状病毒肺炎合并心力衰竭患者的糖皮质激素治疗]
Rev Clin Esp. 2022 May;222(5):309-310. doi: 10.1016/j.rce.2021.11.002. Epub 2021 Nov 20.
2
Adverse outcomes in patients with heart failure admitted for COVID‑19 in association with the use of renin-angiotensin‑aldosterone system inhibitors.
Pol Arch Intern Med. 2022 Jan 28;132(1). doi: 10.20452/pamw.16126. Epub 2021 Oct 22.
3
Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study.因COVID-19住院的心力衰竭患者的皮质类固醇治疗：一项多中心回顾性研究。
Intern Emerg Med. 2021 Nov;16(8):2301-2305. doi: 10.1007/s11739-021-02843-4. Epub 2021 Oct 12.
4
[Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain].[西班牙因COVID-19住院的心力衰竭患者入院时的临床特征及死亡风险因素]
Rev Clin Esp. 2022 May;222(5):255-265. doi: 10.1016/j.rce.2021.06.004. Epub 2021 Jul 17.
5
[Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry].[西班牙新冠肺炎住院患者的临床特征：SEMI-COVID-19登记研究结果]
Rev Clin Esp. 2020 Nov;220(8):480-494. doi: 10.1016/j.rce.2020.07.003. Epub 2020 Jul 19.
6
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.

[Answer to the "Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure" correspondence].

作者信息

Salinas-Botrán A, Pérez-Belmonte L M, Méndez-Bailón M

机构信息

Servicio de Medicina Interna, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, España.

Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga (UMA), Málaga, España.

出版信息

Rev Clin Esp. 2022 May;222(5):310-311. doi: 10.1016/j.rce.2021.11.001. Epub 2021 Nov 20.

DOI:10.1016/j.rce.2021.11.001
PMID:34840339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8604690/
Abstract
摘要